Product
Tritace
1 clinical trial
1 indication
Indication
bioequivalenceClinical trial
Open-label Randomized Crossover Two Period Single Dose Bioequivalence Study of Two Formulations Ramipril Tablets 10 mg (Pharmtechnology LLC, Republic of Belarus) and Tritace® Tablets 10 mg (Sanofi-Aventis Deutschland GmbH, Germany) in Healthy Volunteers Under Fasting ConditionsStatus: Completed, Estimated PCD: 2022-08-02